Jayapal Statement on the Passage of the HALT Fentanyl Act
WASHINGTON, DC — U.S. Representative Pramila Jayapal (WA-07) released the following statement on the House passage of the HALT Fentanyl Act:
“The United States has made tremendous progress in the fight to protect our communities from fentanyl, and while there is still much more to be done, the HALT Fentanyl Act is far too broad and ignores all medical uses of ‘fentanyl-related substances.’ These substances need to be controlled — but when prescribed and used as directed, many of them serve as critical pain management tools for countless Americans.
“This legislation is just another performative overreach by Republicans to say that they know better than doctors about what is best for their patients. We don’t need to criminalize care and expand harsh mandatory minimum sentencing requirements. We need well-thought-out and meaningful solutions that address the root causes of addiction, expand resources to help those struggling, and work with medical professionals.
“But that’s not what President Trump and Republicans are doing. Instead of expanding funding for the Substance Abuse and Mental Health Services Administration (SAMHSA) — which supports naloxone programs, treatment programs, and prevention efforts — President Trump has essentially dissolved the agency, firing more than a third of its staff and proposing a budget that cuts $1 billion of its funding. Republicans are also working to cut at least $600 billion from Medicaid, which will seriously undermine our ability to address the opioid epidemic. If President Trump and Republicans were serious about addressing these issues, there are proven solutions we can act upon to save lives — but the HALT Fentanyl Act is not one of them.”
Issues: Public Safety & Criminal Justice